- Edaravone may be the first ALS treatment approved in U.S. in more than 20 years.
- As many as 30,000 Americans are estimated to be affected by ALS and more than 5,600 are diagnosed annually.
Raising awareness about how muscular dystrophy, ALS and related muscle-debilitating diseases impact the families we serve is critical for educating people about the urgent need for action and support.
Vice President of Public Relations
3300 E. Sunrise Drive, Tucson, AZ 85718
(520) 529-5305 telephone; (520) 529-5353 fax
MDA is here to provide assistance with local or national stories about MDA, our lifesaving research and treatments, family stories/interviews, treatment protocols, expert perspectives on diseases in MDA's program, fundraising events, corporate partnerships and other issues related to muscular dystrophy, ALS and related muscle-debilitating diseaes. Call our public relations department at (520) 529-5317 or email firstname.lastname@example.org for assistance.